| pubmed-article:19934775 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19934775 | lifeskim:mentions | umls-concept:C0149925 | lld:lifeskim |
| pubmed-article:19934775 | lifeskim:mentions | umls-concept:C0022972 | lld:lifeskim |
| pubmed-article:19934775 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:19934775 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:19934775 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19934775 | pubmed:dateCreated | 2009-12-25 | lld:pubmed |
| pubmed-article:19934775 | pubmed:abstractText | The Lambert Eaton myasthenic syndrome (LEMS) is a paraneoplastic disorder associated with raised serum voltage-gated calcium channel (VGCC) antibodies in patients with small cell lung cancer (SCLC). VGCC can also be found in patients with SCLC and cerebellar ataxia. This was a prospective study to assess the incidence of clinical and subclinical LEMS or other neurologic disease in patients with SCLC. | lld:pubmed |
| pubmed-article:19934775 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19934775 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19934775 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19934775 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19934775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19934775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19934775 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19934775 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19934775 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:VincentAngela... | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:Newsom-DavisJ... | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:LangBethanB | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:HanChengC | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:BradburyPenny... | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:TalbotDenisD | lld:pubmed |
| pubmed-article:19934775 | pubmed:author | pubmed-author:PayneMirandaM | lld:pubmed |
| pubmed-article:19934775 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19934775 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:19934775 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19934775 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19934775 | pubmed:pagination | 34-8 | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:meshHeading | pubmed-meshheading:19934775... | lld:pubmed |
| pubmed-article:19934775 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19934775 | pubmed:articleTitle | Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer. | lld:pubmed |
| pubmed-article:19934775 | pubmed:affiliation | Department of Medical Oncology, University of Oxford Medical Oncology Unit, Oxford, United Kingdom. | lld:pubmed |
| pubmed-article:19934775 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19934775 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19934775 | lld:pubmed |
